Antimicrobial Agents and Chemotherapy 2005-10-01

Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.

P Holzmuller, D Sereno, J-L Lemesre

Index: Antimicrob. Agents Chemother. 49(10) , 4406-9, (2005)

Full Text: HTML

Abstract

We previously documented the induction of Leishmania amastigote apoptosis by trivalent antimony (SbIII) and nitric oxide (NO). We demonstrate here that SbIII-resistant amastigotes were resistant to NO toxicity when delivered extracellularly by NO donors or intracellularly via macrophage activation. Shared biochemical targets for SbIII and NO resistance in Leishmania are discussed.

Related Compounds

  • Potassium antimony...

Related Articles:

Therapy and disease concepts: the history (and future?) of antimony in cancer.

2002-01-01

[J. Hist. Med. Allied Sci. 57(1) , 61-78, (2002)]

Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis.

2011-01-01

[Cytometry. A 79(1) , 35-45, (2011)]

Effects of antimony on aquatic organisms (Larva and embryo of Oryzias latipes, Moina macrocopa, Simocephalus mixtus, and Pseudokirchneriella subcapitata).

2009-05-01

[Chemosphere 75(7) , 889-93, (2009)]

Cys-113 and Cys-422 form a high affinity metalloid binding site in the ArsA ATPase.

2006-04-14

[J. Biol. Chem. 281(15) , 9925-34, (2006)]

A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.

2008-03-01

[Mol. Biochem. Parasitol. 158(1) , 95-9, (2008)]

More Articles...